Novartis India trades higher on the bourses

18 Sep 2013 Evaluate

Novartis India is currently trading at Rs. 395.00, up by 4.75 points or 1.22% from its previous closing of Rs. 390.25 on the BSE.

The scrip opened at Rs. 390.00 and has touched a high and low of Rs. 397.50 and Rs. 385.00 respectively. So far 13066 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 693.85 on 30-Nov-2012 and a 52 week low of Rs. 361.00 on 03-Sep-2013.

Last one week high and low of the scrip stood at Rs. 414.75 and Rs. 380.20 respectively. The current market cap of the company is Rs. 1261.81 crore.

The promoters holding in the company stood at 75.00% while Institutions and Non-Institutions held 3.41% and 21.59% respectively.

Novartis India has entered into a Supply & Distribution Agreement with Themis Medicare on August 16, 2013. As per agreement, Themis has agreed to manufacture and supply and Novartis has agreed long term exclusive purchase from Themis Diclofenac Sodium 75 mg per ml Injection as finished dosage pharmaceutical form on certain commercial terms and conditions for Indian market.

Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.

 

 

Novartis Share Price

1040.00 -14.95 (-1.42%)
14-Nov-2024 12:28 View Price Chart
Peers
Company Name CMP
Redington 194.05
Adani Enterprises 2810.00
Amrapali Industries 17.79
Rashi Peripheral 368.15
Compuage Infocom 2.71
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.